Cancer diagnostics company creates medical advisory board with GI experts

Written by Eric Oliver | July 02, 2019 | Print  |

Cernostics created a medical advisory board with experts on gastroesophageal reflux disease, Barrett's esophagus and esophageal cancer to assist the company going forward.

What you should know:

1. The board includes:

2. Cernostics creates tissue-based diagnostic tests that aim to improve patient outcomes and lower care costs.

"Timing is right to bring together this world-class group of medical advisors to provide strategic insights into our evidence development and market access strategies," said Cernostics CEO Mike Hoerres.

More articles on gastroenterology:
3 things to know about outpatient cervical disc replacement
10 things to know about spine surgery for ASCs in 2019
Outpatient revision minimally invasive lumbar decompression: 4 notes on ASC vs. HOPD

© Copyright ASC COMMUNICATIONS 2019. Interested in LINKING to or REPRINTING this content? View our policies by clicking here.

To receive the latest hospital and health system business and legal news and analysis from Becker's Hospital Review, sign-up for the free Becker's Hospital Review E-weekly by clicking here.